Fuller & Thaler Asset Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
Fuller & Thaler Asset Management's VCYT Position: Q3 2026 in Review
Fuller & Thaler Asset Management increased its Veracyte (VCYT) stake by 7.4% in Q3 2026, buying an estimated $5.41M and bringing the position to 1,622,061 shares worth $74.7M. The position accounts for 0.22% of the portfolio, ranked #178.
Fuller & Thaler Asset Management first reported a position in VCYT in Q4 2018 and has held it in 8 quarters since. The position peaked at $88.7M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.
- Fuller & Thaler Asset Management held 1,622,061 shares of Veracyte worth $74.7M as of Q3 2026.
- Fuller & Thaler Asset Management bought 112,312 Veracyte shares in Q3 2026, an estimated $5.41M.
- Veracyte made up 0.22% of Fuller & Thaler Asset Management's portfolio in Q3 2026, its #178 holding.
- Fuller & Thaler Asset Management first reported a position in Veracyte in Q4 2018 and has held it in 8 quarters since.
- Fuller & Thaler Asset Management's Veracyte position peaked at $88.7M in Q2 2026.
- 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.
Based on Fuller & Thaler Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.